Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab in first line (1L) metastatic non-squamous NSCLC
Phase: 3Phase III in Spain, 2Phase II, 1Phase I in Spain